colforsin has been researched along with Pancreatic Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beekman, JM; Berkers, G; Brunsveld, JE; de Poel, E; de Winter-de Groot, KM; Dompeling, E; Eijkemans, MJC; Hagemeijer, MC; Heida-Michel, S; Jans, SR; Koppelman, GH; Kruisselbrink, E; Muilwijk, D; Oppelaar, H; Roukema, J; Suen, SWF; van der Eerden, MM; van der Ent, CK; van der Meer, R; van Mourik, P; van Panhuis, H; Vonk, AM; Vries, R; Weersink, EJM; Zomer-van Ommen, DD | 1 |
1 other study(ies) available for colforsin and Pancreatic Insufficiency
| Article | Year |
|---|---|
Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.
Topics: Biomarkers; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Progression; Exocrine Pancreatic Insufficiency; Humans; Mutation; Organoids | 2022 |